OptimizeRx Corp Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.03M0.07M1.11M1.99M4.68M6.50M7.22M7.75M12.13M21.21M24.60M43.31M61.29M62.45M71.52M92.13M
Cost of Revenue 0.12M2.37M3.22M3.62M3.41M6.17M9.00M9.16M19.21M25.65M23.48M28.62M32.75M
Gross Profit 1.87M2.82M3.28M3.60M4.34M5.95M12.21M15.44M24.11M35.64M38.97M42.90M59.38M
Operating items
Depreciation & Amortization - Total 0.01M0.01M0.00M0.02M0.05M0.06M0.08M0.10M0.11M0.09M0.10M0.11M
Research & Development 0.04M0.08M
Share-based Compensation (IS) 1.32M0.01M
Selling, General & Administrative 0.16M0.05M0.27M0.29M27.70M33.49M
Restructuring Costs 0.40M5.08M6.86M9.19M15.59M20.99M27.70M44.30M49.80M
Other Operating Expenses 4.41M1.79M2.57M2.06M2.79M3.90M4.19M0.82M1.18M2.78M3.46M5.15M-20.23M-16.16M-2.14M23.17M
Operating Expenses 4.61M1.92M2.57M2.33M3.09M4.31M4.20M5.92M8.08M12.03M19.13M26.24M35.28M51.26M69.30M73.08M
Operating Income -4.59M-1.85M-1.45M-0.45M-0.27M-1.03M-0.60M-1.58M-2.13M0.18M-3.69M-2.14M0.36M-12.29M-26.40M-13.71M
EBIT -4.59M-1.85M-1.45M-0.45M-0.27M-1.03M-0.60M-1.58M-2.13M0.18M-3.69M-2.14M0.36M-12.29M-26.40M-13.71M
Non-operating items
Interest & Investment Income 0.00M-469.00246.00935.000.00M0.04M0.03M0.05M0.29M0.07M0.02M0.85M2.19M0.33M
Other Non Operating Income 0.00M0.29M0.05M-0.35M-0.07M0.02M0.85M0.50M0.15M
Non Operating Income -0.16M-0.67M369.00246.00935.000.00M0.04M0.03M0.05M-0.35M-0.07M0.02M0.85M1.24M-5.68M
Net income details
EBT -4.56M-2.01M-2.12M-0.45M-0.27M-1.03M-0.60M-1.54M-2.10M0.23M-4.04M-2.21M0.38M-11.44M-25.16M-19.39M
Tax Provisions -0.90M-7.60M-4.07M
Profit After Tax -4.56M-2.01M-2.12M-0.45M-0.27M-1.03M-0.60M-1.54M-2.10M0.23M-3.14M-2.21M0.38M-11.44M-17.57M-20.11M
Income from Continuing Operations -4.56M-2.01M-2.12M-0.45M-0.27M-1.03M-0.60M-1.54M-2.10M0.23M-3.14M-2.21M0.38M-11.44M-17.57M-15.31M
Consolidated Net Income -4.56M-2.01M-2.12M-0.45M-0.27M-1.03M-0.60M-1.54M-2.10M0.23M-3.14M-2.21M0.38M-11.44M-17.57M-15.31M
Income towards Parent Company -4.56M-2.01M-2.12M-0.45M-0.27M-1.03M-0.60M-1.54M-2.10M0.23M-3.14M-2.21M0.38M-11.44M-17.57M-15.31M
Net Income towards Common Stockholders -4.56M-2.01M-2.12M-0.45M-0.27M-1.03M-0.60M-1.54M-2.10M0.23M-3.14M-2.21M0.38M-11.44M-17.57M-20.11M
Additional items
EPS (Basic) -0.15-0.15-0.03-0.02-0.04-0.02-0.05-0.210.02-0.23-0.150.02-0.64-1.03-1.10
EPS (Weighted Average and Diluted) -0.15-0.15-0.030.01-0.04-0.210.02-0.23-0.150.02-0.64-1.03-1.10
Shares Outstanding (Weighted Average) 1.47M1.58M1.58M1.64M2.60M3.22M3.30M3.25M12.01M14.17M15.11M17.77M17.15M18.15M18.42M
Shares Outstanding (Diluted Average) 13.23M13.92M14.21M21.20M24.01M9.82M11.86M13.39M14.83M17.69M17.78M17.12M18.29M
EBITDA -4.59M-1.85M-1.45M-0.45M-0.26M-1.02M-0.59M-1.56M-2.08M0.24M-3.61M-2.04M0.47M-12.21M-26.30M-13.60M
Interest Expenses -0.00M-0.11M0.96M-100.001.45M6.16M
Tax Rate 22.22%30.19%21.00%